HNGE
Hinge Health, Inc.
NYSE · Healthcare · Medical - Healthcare Information Services · US
$119.94
+2.65%Next report
Analyst consensus
- Next report date
- Feb 9, 2027
- EPS estimate
- $0.71
- Revenue estimate
- $247.0M
Latest reported
- Last report date
- Nov 2, 2026
- EPS actual
- $0.71
- EPS estimate
- $0.58
- Revenue actual
- $235.0M
- Revenue estimate
- $224.8M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 3
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +19.1%
- Revenue beats (12Q)
- 3
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $129
- PT range
- $90 – $150
- Analysts
- 13
12 Buy1 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Nov 2, 2026 | $0.58 | $0.71 | Beat 23.26% | $235.0M |
| Aug 4, 2026 | $0.61 | $0.59 | Miss -4.07% | $212.8M |
| May 5, 2026 | $0.39 | $0.45 | Beat 15.38% | $182.3M |
| Nov 4, 2025 | $0.24 | $0.34 | Beat 41.67% | $154.2M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Feb 9, 2027